Ockham's razor and the metabolic syndrome

Area of Science:

• Metabolic surgery
• Gastroenterology
• Endocrinology

Background:

• Bariatric/metabolic surgery yields extensive benefits across organ systems, not fully explained by weight loss alone.
• Remission of type 2 diabetes, improved islet function, reduced cancer prevalence, and increased brain gray matter are observed post-surgery.
• Metabolic syndrome may represent a unified defect in carbohydrate and lipid utilization rather than distinct diseases.

Purpose of the Study:

• To review the unexplained systemic effects of bariatric/metabolic surgery.
• To propose a unifying hypothesis for metabolic syndrome based on a foregut-derived dysmetabolic signal.
• To explore novel therapeutic avenues targeting this signal.

Main Methods:

• Literature review and synthesis of existing research on bariatric surgery outcomes.
• Analysis of the proposed dysmetabolic signaling pathway involving carbohydrate and lipid metabolism.
• Discussion of the role of foregut-food interaction in metabolic regulation.

Main Results:

• Weight loss does not fully account for the observed improvements in type 2 diabetes, islet function, cancer risk, brain structure, and mortality.
• A dysmetabolic signal from the foregut, triggered by food, may impair the tricarboxylic acid cycle, leading to lactate accumulation and altered glucose/insulin levels.
• Surgical reduction of foregut-food contact is hypothesized to attenuate this signal.

Conclusions:

• Bariatric surgery's benefits suggest a shared underlying defect in metabolic syndrome, potentially mediated by a foregut signal.
• Identifying and characterizing this signal could pave the way for new pharmacological interventions for metabolic disorders.
• Targeting the foregut-derived signal offers a novel therapeutic strategy beyond traditional weight management.